Ocugen, Inc. (OCGN) P/E Ratio History
Historical price-to-earnings valuation from 2020 to 2020
Loading P/E history...
OCGN Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Ocugen, Inc. (OCGN) trades at a price-to-earnings ratio of -6.3x, with a stock price of $1.44 and trailing twelve-month earnings per share of $-0.22.
The current P/E is 197% below its 5-year average of 6.5x. Over the past five years, OCGN's P/E has ranged from a low of 6.5x to a high of 6.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, OCGN trades at a 128% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, OCGN trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OCGN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OCGN P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $74B | 17.1Lowest | 2.70Best | +8%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
OCGN Historical P/E Data (2020–2020)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2020 Q3 | Wed Sep 30 2020 00:00:00 GM | $0.31 | $0.05 | 6.5x | +0% |
Average P/E for displayed period: 6.5x
See OCGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OCGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OCGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOCGN — Frequently Asked Questions
Quick answers to the most common questions about buying OCGN stock.
Is OCGN stock overvalued or undervalued?
OCGN trades at -6.3x P/E, below its 5-year average of 6.5x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does OCGN's valuation compare to peers?
Ocugen, Inc. P/E of -6.3x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is OCGN's PEG ratio?
OCGN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2020-2020.